DOW JONES22,149.19+512.41 2.37%
S&P 5002,607.66+66.19 2.60%
NASDAQ7,714.64+212.26 2.83%

Evofem Biosciences Q4 EPS $(0.27) Beats $(0.29) Estimate

Evofem Biosciences (NASDAQ:EVFM) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.29) by 6.9 percent. This is a 53.45 percent increase over losses of $(0.58) per share from

Benzinga · 03/12/2020 12:24

Evofem Biosciences (NASDAQ:EVFM) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.29) by 6.9 percent. This is a 53.45 percent increase over losses of $(0.58) per share from the same period last year.